CDE News - CorporateDispatch - Your News Feed

EU regulator finds possible link between AstraZeneca vaccine and rare blood clots – UPDATE

BRUSSELS, April 7 (Reuters) - The European Medicines Agency (EMA) said on Wednesday it had found a possible link between AstraZeneca's coronavirus vaccine and reports of very rare cases of…

Read More Here

EU expects impact on vaccination plans after EMA announcement on AstraZeneca

European Union health ministers have been told the EU drug regulator's decision on the safety of the AstraZeneca vaccine is expected to have an immediate impact on vaccination plans and…

Read More Here

EU regulator to probe ethical standards of Sputnik vaccine trials

The EU drug regulator will begin investigations next week on whether clinical trials of Russia's Sputnik V COVID-19 vaccine followed global clinical and scientific guidelines, the Financial Times reported on…

Read More Here

EMA official sees clear ‘association’ between AstraZeneca vaccine and rare blood clots in brain – UPDATE

A senior official at Europe's medicines regulator has said there is a clear "association" between AstraZeneca's COVID-19 vaccine and very rare blood clots in the brain, though the direct cause…

Read More Here

EU drug regulator investigating 62 reports of rare clotting worldwide – chief

Europe's drug regulator is investigating 62 cases worldwide of a rare blood clotting condition which has prompted some countries to limit the use of AstraZeneca's COVID-19 vaccine, its chief Emer…

Read More Here

All eyes on EU regulator as AstraZeneca decision to be released

The European Medicines Agency (EMA) is due to provide an assessment on Thursday of the safety of Astrazeneca's vaccine against Covid-19 after several countries temporarily suspended use of the jab…

Read More Here

Explainer: How worried should we be about reports of blood clots and AstraZeneca’s vaccine?

FRANKFURT/PARIS (Reuters) - Europe’s drug watchdog is reviewing a small number of reports of bleeding, blood clots and low platelet counts in people who have received AstraZeneca’s coronavirus vaccine. The…

Read More Here

European Medicines Agency: Benefits of AstraZeneca vaccine continue to outweigh the risks – UPDATED

AMSTERDAM (Reuters) - Europe's medicines watchdog on Tuesday said the benefits of AstraZeneca's COVID-19 vaccine continue to outweigh the risks after several countries halted its use due to concerns about…

Read More Here

EMA gives green light to J&J’s single-shot COVID-19 vaccine

March 11 (Reuters) - The European Union's drugs regulator on Thursday recommended conditionally approving Johnson & Johnson's single dose COVID-19 vaccine, as the bloc seeks to speed up a stuttering…

Read More Here

EU Commission considering emergency approvals for COVID-19 vaccines

BRUSSELS, March 2 (Reuters) - The European Commission said on Tuesday that it was considering emergency approvals for COVID-19 vaccines as a faster alternative to more rigorous conditional marketing authorisations…

Read More Here

Johnson & Johnson submits vaccine for EMA’s approval for use in Europe

Anadolu - Johnson & Johnson on Tuesday applied for conditional marketing authorization of its COVID-19 vaccine, the European Medicines Agency (EMA) said in a statement. “EMA’s human medicines committee (CHMP)…

Read More Here

German health minister open to using Russia, Chinese vaccines

Berlin (dpa) - German Health Minister Jens Spahn has said he is open to the use of coronavirus vaccines from Russia or China in Germany, as a debate over the availability of vaccines…

Read More Here

EMA – Gap between Pfizer doses should be three weeks

Amsterdam (dpa) - The European Medicines Agency (EMA) has tightened its guidelines for the use of the Pfizer/BioNTech vaccine in a resolution published on Thursday, according to which the second dose has to…

Read More Here

Germany pushes EU to approve vaccine before Christmas

Germany continued to pile pressure on the EU's regulatory agency, asking it to approve a coronavirus vaccine before Christmas, The Guardian reported this morning. “Our goal is an approval before…

Read More Here

EU agency assessing COVID vaccines hit by cyberattack

The European Medicines Agency (EMA) has launched an investigation after being hit by a cyberattack, the agency said in a brief statement. "EMA has been the subject of a cyberattack.…

Read More Here

EU drug regulator to use UK data on adverse effects in assessment of Pfizer vaccine

BRUSSELS (Reuters) - The European Union drug regulator will use data from Britain and other countries outside the EU on the safety of Pfizer-BioNTech's COVID-19 vaccine before deciding whether to…

Read More Here

UPDATE – Hackers steal Pfizer/BioNTech COVID-19 vaccine data in Europe, companies say

LONDON, Dec 9 (Reuters) - U.S. drugmaker Pfizer and its German partner BioNTech said on Wednesday that documents related to their development of a COVID-19 vaccine had been "unlawfully accessed"…

Read More Here

Europe lays ground for fast-tracking COVID-19 vaccine reviews

The European health regulator has started reviewing data on AstraZeneca and Oxford University's potential COVID-19 vaccine in real time, the first of such moves aimed at speeding up any approval…

Read More Here

EU drugs agency evaluates potential coronavirus treatment

The European Medicines Agency said Thursday it will start a rolling review of remdesivir, an investigational therapy for COVID-19 originally developed by drugmaker Gilead to treat Ebola. EMA’s human medicines committee…

Read More Here

UN Committee says Ebola in DR Congo still an international public health emergency

The Ebola outbreak in the eastern Democratic Republic of the Congo (DRC) officially remains a Public Health Emergency of International Concern, experts meeting in Geneva said. The World Health Organization…

Read More Here

World’s biggest anti-malaria vaccine campaign begins in Africa

Some 360,000 children a year in three African countries are to receive a powerful anti-malaria drug as part of a pilot project to help reduce the incidence of the…

Read More Here